Wuhan Aofei Technology Co., Ltd.

China's tremendous potential, talent resources, and well-developed infrastructure attracted the Aofei team, leading to the establishment of Wuhan Aofei Technology Co., Ltd. in Wuhan Optics Valley in 2020. Wuhan Aofei will officially commence operations in March 2021, and we need a large number of outstanding talents to join our team. Wuhan, as a central city, is a nationally important industrial base, scientific and educational base, and comprehensive transportation hub. With the rise of central China as a fulcrum, it has received strong support from national policies. In 2017, it launched the "Project of Retaining One Million College Students in Wuhan for Entrepreneurship and Employment" and formulated a series of talent retention policies, revitalizing Wuhan, one of China's four major scientific and educational central cities. Wuhan Aofei Technology Co., Ltd. is located in the Wuhan Optics Valley International Biomedical Industry Base, with a 1,200-square-meter laboratory, complete and comprehensive synthesis and analysis equipment, and a excellent and humanized office environment. The park has convenient transportation, and canteens and dormitories are fully available. Wuhan Aofei adheres to the excellent corporate culture of Aofei in the United States and the spirit of striving for perfection in technology. The company implements a "family" culture, putting people first, and providing employees with a warm working environment like home. While striving to create a clean, safe, and comfortable working environment, it elevates chemical synthesis to the pursuit of synthetic art. Basic business: The initial basic business of Wuhan Aofei is pharmaceutical chemistry CRO, mainly focusing on custom synthesis, FTE, process development, and process package optimization and improvement. Future development: Gradually enter the terminal CRO and CDMO business of the pharmaceutical industry chain, develop Class 1 new drugs, and become a well-known listed enterprise at home and abroad.